Maximilian Diehn

机构：Cancer Prevention Institute of California, Palo Alto University, Stanford Medicine, Stanford Cancer Institute, Stanford University · ORCID：0000-0003-2032-0581

发表论文 761 篇 · 总被引 59337 次 · h-index 89

代表论文

• AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer (2026 · Nature Medicine · 被引 46)
• Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 34)
• Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs (2026 · Journal of Thoracic Oncology · 被引 10)
• Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases (2025 · Journal of Thoracic Oncology · 被引 6)
• Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology (2026 · Cell · 被引 4)
• Ensemble learning of pathology foundation models for precision oncology (2026 · Cancer Cell · 被引 1)